Ad is loading...
ABVIX
Price
$20.11
Change
+$0.15 (+0.75%)
Updated
Nov 22 closing price
VVIAX
Price
$70.26
Change
+$0.54 (+0.77%)
Updated
Nov 22 closing price
Ad is loading...

ABVIX vs VVIAX

Header iconABVIX vs VVIAX Comparison
Open Charts ABVIX vs VVIAXBanner chart's image
AB Large Cap Value I
Price$20.11
Change+$0.15 (+0.75%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$70.26
Change+$0.54 (+0.77%)
VolumeN/A
CapitalizationN/A
ABVIX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ABVIX vs. VVIAX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVIX is a StrongBuy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. ABVIX (472M). VVIAX pays higher dividends than ABVIX: VVIAX (2.36) vs ABVIX (1.28). ABVIX was incepted earlier than VVIAX: ABVIX (20 years) vs VVIAX (24 years). ABVIX is a more actively managed with annual turnover of: 45.00 vs. VVIAX (10.00). VVIAX has a lower initial minimum investment than ABVIX: VVIAX (3000) vs ABVIX (2000000). VVIAX (26.09) and ABVIX (25.66) have marching annual gain over last year. VVIAX return over 5 years is better than : 53.09 vs. ABVIX (42.36).
ABVIXVVIAXABVIX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years24 years-
Gain YTD23.21019.672118%
Front LoadN/AN/A-
Min. Initial Investment2000000300066,667%
Min. Initial Investment IRAN/AN/A-
Net Assets472M184B0%
Annual Yield % from dividends1.282.3654%
Returns for 1 year25.6626.0998%
Returns for 3 years9.1524.7737%
Returns for 5 years42.3653.0980%
Returns for 10 years53.13112.2647%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics